Who Buys Liraglutide from India — 121 Importers Behind a $4.3M Market
India's liraglutide import market is served by 121 active buyers who collectively imported $4.3M across 416 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 52.6% market share, followed by M/S MEDPRO PHARMACEUTICA PTY LTD and SUCCEED HOLDINGS LTD.. The top 5 buyers together control 93.9% of total import value, reflecting a concentrated buyer landscape.
Top Liraglutide Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading liraglutide importer from India, holding a 52.6% share of the $4.3M market across 416 shipments from 121 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), M/S MEDPRO PHARMACEUTICA PTY LTD (SOUTH AFRICA), SUCCEED HOLDINGS LTD. (HONG KONG), DR,ANTHONY ANDRE, (UNITED STATES), PHARMACHEM PRIVATE LIMITED (NEPAL) — collectively control 93.9% of total import value.
Top Liraglutide Buyers & Importers
Ranked by import value · 121 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM DIAVIC INJ 6MG/ML 2X1'S PEN NL -GST INVOICE NODIAVIC INJECTION 6MG/ML [1304 PACK X 1X10'S]DIAVIC INJ 6MG/ML 3X1'S PEN SE -GST INVOICE NO | $2.3M | 5 | 52.6% |
| 2 | M/S MEDPRO PHARMACEUTICA PTY LTDSOUTH AFRICA GILIPTRA 6MG/ML 3X 3ML PREFILLED PENGILIPTRA 6MG/ML 2X 3ML PREFILLED PENSAXENDA INJECTION# | $1.4M | 5 | 32.6% |
| 3 | SUCCEED HOLDINGS LTD.HONG KONG | $324.7K | 5 | 7.6% |
| 4 | DR,ANTHONY ANDRE,UNITED STATES SAXENDA INJECTION#VICTOZA LIRAGLUTIDE PENLIRAGLUTIDE INJECTION 18MG/3ML | $27.6K | 5 | 0.6% |
| 5 | PHARMACHEM PRIVATE LIMITEDNEPAL VICTOZA LIRAGLUTIDE H.L.MEDICINENOSVICTOZA LIRAGLUTIDE H.L.MEDICINEVICTOZA LIRAGLUTIDE BAT | $20.0K | 5 | 0.5% |
| 6 | CHEMO LABORATORIOS LICONSA, S.ASPAIN LIRAGLUTIDE 6MG/ML SOLUTION FOR INJECTIONLIRAGLUTIDE INJECTION 6 MG/ML.NOSLIRAGLUTIDE 6 MG/ML SOLUTION FOR INJECTION | $10.6K | 5 | 0.2% |
| 7 | PURCHASE MANAGERITALY LIRAGLUTIDE 6MG/ML SOLUTION FOR INJECTION | $8.1K | 5 | 0.2% |
| 8 | CIPLA BRASIL IMPORTADORA E DISTRIBUBRAZIL LIRAGLUTIDE INJECTION 18MG/3ML,LIRAGLUTIDE INJECTION 6MG/MLPLACEBO FOR LIRAGLUTIDE INJECTION 18MG/3ML, | $5.0K | 5 | 0.1% |
| 9 | EMIRATES POST COMPANYUNITED ARAB EMIRATES VICTOZA 6 - LIRAGLUTIDE 6 -VICTOZA 6MG INJ-LIRAGLUTIDE-VICTOZA 6MG INJ - LIRAGLUTIDE - | $4.9K | 5 | 0.1% |
| 10 | BZ COMPNAT LIMITEDTHAILAND | $4.9K | 5 | 0.1% |
| 11 | CIPLA BRASIL IMPORTADORA EBRAZIL LIRAGLUTIDE INJECTION 18MG/3ML,LIRAGLUTIDE INJECTION 6MG/MLPLACEBO FOR LIRAGLUTIDE INJECTION 18MG/3ML, | $4.8K | 5 | 0.1% |
| 12 | XXOIMXXNE XXDUNITED KINGDOM | $3.9K | 5 | 0.1% |
| 13 | PROIMMUNE LIMITEDUNITED KINGDOM | $3.9K | 5 | 0.1% |
| 14 | CIPLA BRASIL IMPORTADORA E DISTRIBULDORA DE MEDICAMENTOS LIMITEDBRAZIL LIRAGLUTIDE INJECTION 18MG/3ML,LIRAGLUTIDE INJECTION 6MG/MLPLACEBO FOR LIRAGLUTIDE INJECTION 18MG/3ML, | $3.3K | 5 | 0.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Liraglutide — and from which countries?
Flow of Liraglutide exports from India: each country's share and the named importers behind the numbers
Liraglutide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Belgium
Belgium emerges as the first largest importing country, achieving a total trade value of $2.3M through 7 shipments. This represents a market share of 52.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $2.3M (99.9% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $321.9K, indicating premium pricing strategy compared to the market average of $10.3K.
Belgium is a key market for Liraglutide imports, representing 52.7% of total trade value.
2South Africa
South Africa emerges as the second largest importing country, achieving a total trade value of $1.4M through 3 shipments. This represents a market share of 32.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Africa has a diverse importer base, with their top importers including:
• M/S MEDPRO PHARMACEUTICA PTY LTD - $1.4M (100.0% of country's total business)
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $465.2K, indicating premium pricing strategy compared to the market average of $10.3K.
South Africa is a key market for Liraglutide imports, representing 32.6% of total trade value.
3Hong Kong
Hong Kong emerges as the third largest importing country, achieving a total trade value of $324.7K through 2 shipments. This represents a market share of 7.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hong Kong has a diverse importer base, with their top importers including:
• SUCCEED HOLDINGS LTD. - $324.7K (100.0% of country's total business)
Key Insight: Hong Kong demonstrates strong market positioning with an average shipment value of $162.3K, indicating premium pricing strategy compared to the market average of $10.3K.
Hong Kong is a key market for Liraglutide imports, representing 7.6% of total trade value.
4Saudi Arabia
Saudi Arabia emerges as the fourth largest importing country, achieving a total trade value of $152.5K through 0 shipments. This represents a market share of 3.6% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $152.5K, indicating premium pricing strategy compared to the market average of $10.3K.
Saudi Arabia is a key market for Liraglutide imports, representing 3.6% of total trade value.
5United States
United States emerges as the fifth largest importing country, achieving a total trade value of $31.3K through 2 shipments. This represents a market share of 0.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• DR,ANTHONY ANDRE, - $27.6K (88.3% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $15.6K, indicating premium pricing strategy compared to the market average of $10.3K.
United States is a key market for Liraglutide imports, representing 0.7% of total trade value.
Buyer Segment Analysis
TransData Nexus Liraglutide buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Liraglutide exports from India amounted to $4.3 million across 416 shipments, involving 53 exporters and 121 buyers across 36 importing countries. The repeat buyer rate stands at 58.7%, suggesting a stable demand base.
Buyer Segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $2.25M) and M/S MEDPRO PHARMACEUTICA PTY LTD (South Africa, $1.40M) fall into this category. These distributors typically procure large volumes to supply regional markets, ensuring consistent availability to healthcare providers. Their order patterns are characterized by bulk purchases aligned with market demand forecasts.
2. Re-exporters: SUCCEED HOLDINGS LTD. (Hong Kong, $0.32M) exemplifies this segment. Operating in strategic trade hubs, re-exporters import Liraglutide for redistribution to neighboring regions, leveraging favorable trade agreements and logistical advantages. Their purchasing behavior is influenced by regional demand fluctuations and trade policies.
3. Healthcare Providers: Entities such as DR. ANTHONY ANDRE (United States, $0.03M) and PHARMACHEM PRIVATE LIMITED (Nepal, $0.02M) represent direct procurement by healthcare professionals or institutions. Their orders are typically smaller and more frequent, driven by immediate patient needs and inventory management practices.
4. Contract Manufacturers: CHEMO LABORATORIOS LICONSA, S.A (Spain, $0.01M) and CIPLA BRASIL IMPORTADORA E DISTRIBU (Brazil, $0.01M) may act as contract manufacturers, importing Liraglutide for formulation and packaging under specific brand names. Their procurement is project-based, aligning with production schedules and contractual obligations.
Understanding these segments is crucial for tailoring marketing strategies, optimizing supply chains, and identifying potential growth opportunities in the Liraglutide market.
Country-Specific Import Regulations
TransData Nexus Liraglutide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries—Belgium, South Africa, Hong Kong, Saudi Arabia, and the United States—importing Liraglutide involves navigating specific regulatory frameworks:
1. Belgium:
2. South Africa:
3. Hong Kong:
4. Saudi Arabia:
5. United States:
Navigating these regulatory landscapes requires meticulous planning and adherence to each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Liraglutide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Liraglutide is primarily driven by the global prevalence of type 2 diabetes and obesity. According to the World Health Organization (WHO), over 1 billion people worldwide are affected by obesity, with type 2 diabetes being a significant comorbidity. In September 2025, the WHO added GLP-1 receptor agonists, including Liraglutide, to its Model List of Essential Medicines, underscoring their importance in managing these conditions.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate essential medicines into their public health initiatives, facilitating broader access through subsidized programs and national tenders. The inclusion of Liraglutide in the WHO Essential Medicines List enhances its procurement through international and national tender-based purchasing systems, ensuring availability in public healthcare settings. Our data, indicating 121 buyers across 36 countries, reflects this widespread adoption and the growing recognition of Liraglutide's therapeutic value.
In summary, the combination of high disease prevalence, supportive healthcare policies, and strategic procurement mechanisms positions Liraglutide as a critical component in the global fight against type 2 diabetes and obesity, presenting substantial market opportunities for stakeholders.
Common Questions — Liraglutide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest liraglutide buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $2.3M in imports and a 52.6% market share — the highest of any single liraglutide importer. M/S MEDPRO PHARMACEUTICA PTY LTD (SOUTH AFRICA) and SUCCEED HOLDINGS LTD. (HONG KONG) are the next largest buyers.
QHow many companies buy liraglutide from India?
There are 121 active liraglutide buyers importing from India, with a combined market of $4.3M across 416 shipments to 36 countries. The top 5 buyers hold 93.9% of total import value, while the remaining 116 buyers handle the other 6.1%.
QWhich countries import the most liraglutide from India?
The top importing countries for liraglutide from India are Belgium (52.7%), South Africa (32.6%), Hong Kong (7.6%), Saudi Arabia (3.6%), United States (0.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of liraglutide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for liraglutide from India?
The average import transaction value for liraglutide from India is $10.3K, with an average unit price of $35.91 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Liraglutide buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Liraglutide exports from India amounted to $4.3 million across 416 shipments, involving 53 exporters and 121 buyers across 36 importing countries. The repeat buyer rate stands at 58.7%, suggesting a stable demand base.
Buyer Segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $2.25M) and M/S MEDPRO PHARMACEUTICA PTY LTD (South Africa, $1.40M) fall into this category. These distributors typically procure large volumes to supply regional markets, ensuring consistent availability to healthcare providers. Their order patterns are characterized by bulk purchases aligned with market demand forecasts.
2. Re-exporters: SUCCEED HOLDINGS LTD. (Hong Kong, $0.32M) exemplifies this segment. Operating in strategic trade hubs, re-exporters import Liraglutide for redistribution to neighboring regions, leveraging favorable trade agreements and logistical advantages. Their purchasing behavior is influenced by regional demand fluctuations and trade policies.
3. Healthcare Providers: Entities such as DR. ANTHONY ANDRE (United States, $0.03M) and PHARMACHEM PRIVATE LIMITED (Nepal, $0.02M) represent direct procurement by healthcare professionals or institutions. Their orders are typically smaller and more frequent, driven by immediate patient needs and inventory management practices.
4. Contract Manufacturers: CHEMO LABORATORIOS LICONSA, S.A (Spain, $0.01M) and CIPLA BRASIL IMPORTADORA E DISTRIBU (Brazil, $0.01M) may act as contract manufacturers, importing Liraglutide for formulation and packaging under specific brand names. Their procurement is project-based, aligning with production schedules and contractual obligations.
Understanding these segments is crucial for tailoring marketing strategies, optimizing supply chains, and identifying potential growth opportunities in the Liraglutide market.
Country-Specific Import Regulations
TransData Nexus Liraglutide buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries—Belgium, South Africa, Hong Kong, Saudi Arabia, and the United States—importing Liraglutide involves navigating specific regulatory frameworks:
1. Belgium:
2. South Africa:
3. Hong Kong:
4. Saudi Arabia:
5. United States:
Navigating these regulatory landscapes requires meticulous planning and adherence to each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Liraglutide buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Liraglutide is primarily driven by the global prevalence of type 2 diabetes and obesity. According to the World Health Organization (WHO), over 1 billion people worldwide are affected by obesity, with type 2 diabetes being a significant comorbidity. In September 2025, the WHO added GLP-1 receptor agonists, including Liraglutide, to its Model List of Essential Medicines, underscoring their importance in managing these conditions.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate essential medicines into their public health initiatives, facilitating broader access through subsidized programs and national tenders. The inclusion of Liraglutide in the WHO Essential Medicines List enhances its procurement through international and national tender-based purchasing systems, ensuring availability in public healthcare settings. Our data, indicating 121 buyers across 36 countries, reflects this widespread adoption and the growing recognition of Liraglutide's therapeutic value.
In summary, the combination of high disease prevalence, supportive healthcare policies, and strategic procurement mechanisms positions Liraglutide as a critical component in the global fight against type 2 diabetes and obesity, presenting substantial market opportunities for stakeholders.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 121 global importers of Liraglutide identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 416 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 36 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
416 Verified Shipments
121 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists